460 related articles for article (PubMed ID: 15914212)
1. Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk.
Rietjens IM; Boersma MG; van der Woude H; Jeurissen SM; Schutte ME; Alink GM
Mutat Res; 2005 Jul; 574(1-2):124-38. PubMed ID: 15914212
[TBL] [Abstract][Full Text] [Related]
2. Physiologically based biokinetic (PBBK) model for safrole bioactivation and detoxification in rats.
Martati E; Boersma MG; Spenkelink A; Khadka DB; Punt A; Vervoort J; van Bladeren PJ; Rietjens IM
Chem Res Toxicol; 2011 Jun; 24(6):818-34. PubMed ID: 21446753
[TBL] [Abstract][Full Text] [Related]
3. Flavonoids and alkenylbenzenes: New concepts in bioactivation studies.
Rietjens IM; Al Huseiny W; Boersma MG
Chem Biol Interact; 2011 Jun; 192(1-2):87-95. PubMed ID: 20863818
[TBL] [Abstract][Full Text] [Related]
4. Formation of transient covalent protein and DNA adducts by quercetin in cells with and without oxidative enzyme activity.
van der Woude H; Alink GM; van Rossum BE; Walle K; van Steeg H; Walle T; Rietjens IM
Chem Res Toxicol; 2005 Dec; 18(12):1907-16. PubMed ID: 16359181
[TBL] [Abstract][Full Text] [Related]
5. Environmental and chemical carcinogenesis.
Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
[TBL] [Abstract][Full Text] [Related]
6. Quenching of quercetin quinone/quinone methides by different thiolate scavengers: stability and reversibility of conjugate formation.
Awad HM; Boersma MG; Boeren S; Van Bladeren PJ; Vervoort J; Rietjens IM
Chem Res Toxicol; 2003 Jul; 16(7):822-31. PubMed ID: 12870884
[TBL] [Abstract][Full Text] [Related]
7. Identification of human and murine sulfotransferases able to activate hydroxylated metabolites of methyleugenol to mutagens in Salmonella typhimurium and detection of associated DNA adducts using UPLC-MS/MS methods.
Herrmann K; Engst W; Appel KE; Monien BH; Glatt H
Mutagenesis; 2012 Jul; 27(4):453-62. PubMed ID: 22337896
[TBL] [Abstract][Full Text] [Related]
8. Human cytochrome p450 enzyme specificity for the bioactivation of estragole and related alkenylbenzenes.
Jeurissen SM; Punt A; Boersma MG; Bogaards JJ; Fiamegos YC; Schilter B; van Bladeren PJ; Cnubben NH; Rietjens IM
Chem Res Toxicol; 2007 May; 20(5):798-806. PubMed ID: 17407329
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole.
Miller EC; Swanson AB; Phillips DH; Fletcher TL; Liem A; Miller JA
Cancer Res; 1983 Mar; 43(3):1124-34. PubMed ID: 6825084
[TBL] [Abstract][Full Text] [Related]
10. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
Bolt HM; Foth H; Hengstler JG; Degen GH
Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
[TBL] [Abstract][Full Text] [Related]
11. 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice.
Randerath K; Haglund RE; Phillips DH; Reddy MV
Carcinogenesis; 1984 Dec; 5(12):1613-22. PubMed ID: 6499112
[TBL] [Abstract][Full Text] [Related]
12. Herbal bioactivation, molecular targets and the toxicity relevance.
Chen XW; Serag ES; Sneed KB; Zhou SF
Chem Biol Interact; 2011 Jul; 192(3):161-76. PubMed ID: 21459083
[TBL] [Abstract][Full Text] [Related]
13. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
14. A computational study on the biotransformation of alkenylbenzenes by a selection of CYPs: Reflections on their possible bioactivation.
Pedroni L; Louisse J; Dorne JCM; Dall'Asta C; Dellafiora L
Toxicology; 2023 Apr; 488():153471. PubMed ID: 36863505
[TBL] [Abstract][Full Text] [Related]
15. A comparative in vitro kinetic study of [14C]-eugenol and [14C]-methyleugenol activation and detoxification in human, mouse, and rat liver and lung fractions.
Minet EF; Daniela G; Meredith C; Massey ED
Xenobiotica; 2012 May; 42(5):429-41. PubMed ID: 22188410
[TBL] [Abstract][Full Text] [Related]
16. Bioactivation of the selective estrogen receptor modulator acolbifene to quinone methides.
Liu J; Liu H; van Breemen RB; Thatcher GR; Bolton JL
Chem Res Toxicol; 2005 Feb; 18(2):174-82. PubMed ID: 15720121
[TBL] [Abstract][Full Text] [Related]
17. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
[TBL] [Abstract][Full Text] [Related]
18. Effect of plant extracts on the genotoxicity of 1'-hydroxy alkenylbenzenes.
Marabini L; Galli CL; La Fauci P; Marinovich M
Regul Toxicol Pharmacol; 2019 Jul; 105():36-41. PubMed ID: 30935955
[TBL] [Abstract][Full Text] [Related]
19. Identification of nevadensin as an important herb-based constituent inhibiting estragole bioactivation and physiology-based biokinetic modeling of its possible in vivo effect.
Alhusainy W; Paini A; Punt A; Louisse J; Spenkelink A; Vervoort J; Delatour T; Scholz G; Schilter B; Adams T; van Bladeren PJ; Rietjens IM
Toxicol Appl Pharmacol; 2010 Jun; 245(2):179-90. PubMed ID: 20226806
[TBL] [Abstract][Full Text] [Related]
20. 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. II. Newborn male B6C3F1 mice.
Phillips DH; Reddy MV; Randerath K
Carcinogenesis; 1984 Dec; 5(12):1623-8. PubMed ID: 6499113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
